Celiac Disease Treatment Differs Between Physicians and Academics
Researchers interviewed 169 practicing gastroenterologists and 22 academic experts to determine the treatment recommended and the treatment actually given. Differences were found in the use of IgA anti-endomysial antibodies, human leukocyte antigen DQ2/8 testing, gluten challenge and oat consumption.
Academic experts more frequently recommended CD screening for patients with type 1 diabetes and Down and Turner syndromes, as well as for relatives of CD patients.
Related Articles on Celiac Disease:
Celiac Cases Rising, Cause Unknown
Mayo Clinic Gastroenterologist Details Role of Endoscopic Imaging in Small Bowel
Texas Gastroenterologist Featured for Use of Capsule Endoscopy
© Copyright ASC COMMUNICATIONS 2016. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.
- National Patient Safety Foundation updates Online Patient Safety Curriculum: 6 points
- Kentucky Gov. Matt Bevin wants to transform state's Medicaid program: 7 things to know
- Cloud technology equips the healthcare industry in digital-focused world — 5 observations
- Dr. Wa Xian receives AGA funding for IBD stem cell research: 4 notes
- Vitality Biopharma announces new patent filing for IBD pain relief: 4 notes